Principal Investigator
Elizabeth Franzmann
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20201539
Clinical Trial Summary
An exploratory study to evaluate the safety and effectiveness of APG-157 as neo-adjuvant/Induction therapy for patients with head and neck squamous cell cancer (HNSCC) of the oral cavity
Phase
Phase II
Funding Agency/Sponsor
Industrial
Disease
Head and Neck Cancer
Contact Information
Phone Number
305-243-2647